Genetic variation of Omi/HtrA2 and Parkinson's disease
- 30 November 2008
- journal article
- Published by Elsevier BV in Parkinsonism & Related Disorders
- Vol. 14 (7), 539-543
- https://doi.org/10.1016/j.parkreldis.2008.08.003
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Genetic variability in the mitochondrial serine proteaseHTRA2contributes to risk for Parkinson diseaseHuman Mutation, 2008
- Mutations in the GIGYF2 (TNRC15) Gene at the PARK11 Locus in Familial Parkinson DiseaseAmerican Journal of Human Genetics, 2008
- Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controlsHuman Molecular Genetics, 2008
- The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1Nature, 2007
- Expanding insights of mitochondrial dysfunction in Parkinson's diseaseNature Reviews Neuroscience, 2006
- Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's diseaseHuman Molecular Genetics, 2005
- Neuroprotective Role of the Reaper-Related Serine Protease HtrA2/Omi Revealed by Targeted Deletion in MiceMolecular and Cellular Biology, 2004
- Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant miceNature, 2003
- Score Tests for Association between Traits and Haplotypes when Linkage Phase Is AmbiguousAmerican Journal of Human Genetics, 2002
- Diagnostic Criteria for Parkinson DiseaseArchives of Neurology, 1999